文献速递衰弱、肌少症与跌倒老年慢病共病管理

三种衰弱评估工具对老年心衰患者预后的比较

Comparative prognostic value of three frailty-assessment tools in older patients with heart failure: post hoc analysis of the FRAGILE-HF cohort.
PubMed 文献 · Age Ageing · 2026-01-01

本分析基于FRAGILE-HF队列的961例住院心衰患者(年龄≥65岁,中位80岁),在出院时采用FSI、FRAIL量表和Fried表型评估衰弱,比较其对2年全因死亡的预测价值。结果显示三种工具判定的衰弱比例不同(48.5%、44.5%、55.8%),FRAIL与Fried判定的衰弱与死亡独立相关,Fried模型增量预后价值最高,FSI无显著关联。

要点

  • 三种衰弱工具判定的衰弱比例存在差异,临床选用会影响风险分层。
  • FRAIL量表与Fried表型判定的衰弱与2年全因死亡独立相关,FSI未见显著关联。
  • Fried表型纳入基线模型后对2年全因死亡的增量预后价值最高。

核心结论

  • 不同衰弱评估工具对老年心衰患者2年全因死亡的预后价值存在明显差异,工具选择影响衰弱分类与风险分层,临床需审慎选择。

研究设计与样本

  • FRAGILE-HF研究的post hoc分析,纳入961例年龄≥65岁的住院心衰患者。

主要发现

  • FSI、FRAIL量表和Fried表型判定的衰弱比例分别为48.5%、44.5%和55.8%。
  • 2年随访期间187例(19.5%)患者死亡,Kaplan-Meier分析显示FRAIL与Fried判定的衰弱与较低生存率显著相关,FSI无显著差异。
  • 调整Cox模型中FRAIL的HR为1.31(95%CI 1.01-1.71),Fried为1.35(95%CI 1.04-1.75),FSI为1.11(95%CI 0.84-1.37)。
  • Fried模型纳入基线模型后对2年全因死亡的增量预后价值最高。

关键数值与推荐

  • 研究对象为年龄≥65岁住院心衰患者,随访2年,主要结局为全因死亡。
  • Cox回归调整了MAGGIC风险评分和对数转换的B型利钠肽。

临床怎么用

  • 老年心衰患者进行衰弱评估时应考虑工具差异,优先选择预后验证更充分的工具如FRAIL量表或Fried表型辅助风险分层。

局限性

  • 为post hoc分析,原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In older patients with heart failure, frailty assessment tools potentially have different prognostic value for all-cause mortality. OBJECTIVE: To compare the Frailty Screening Index (FSI), FRAIL scale and Fried phenotype. DESIGN: Post hoc analysis of the FRAGILE-HF study. SUBJECTS: Hospitalised patients (age ≥ 65 years) with heart failure. METHODS: We assessed frailty status at discharge, considered preadmission conditions of patients, using the FSI, FRAIL scale and Fried phenotype models and evaluated the primary outcome (2-year all-cause mortality), prognostic performance using Cox regression analysis (adjusted for the Meta-analysis Global Group in Chronic Heart Failure risk score and log-transformed B-type natriuretic peptide) and discriminative and reclassification abilities (area under the receiver-operating characteristic curve and continuous net reclassification improvement, respectively). RESULTS: Among 961 patients [median age: 80 (IQR, 74-85) years; 41.5% women], frailty was identified in 48.5%, 44.5% and 55.8% by the FSI, FRAIL scale and Fried models, respectively. During the 2-year follow-up, 187 (19.5%) patients died. On Kaplan-Meier analysis, frailty defined by the FRAIL and Fried was associated with significantly lower survival; FSI showed no significant difference. Adjusted Cox models showed that frailty was independently associated [HR (95% CI)] with mortality in FRAIL [1.31 (1.01-1.71)] and Fried [1.35 (1.04-1.75)] but not FSI [1.11 (0.84-1.37)]. The Fried model, incorporated into the baseline model, yielded the highest incremental prognostic value for 2-year all-cause mortality. CONCLUSIONS: Frailty assessment using different tools yields varying results, with notable differences in their prognostic value for 2-year all-cause mortality. The frailty assessment tool influences both frailty classification and risk stratification and warrants careful clinical selection.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Nakade T, Maeda D, Matsue Y, et al. Comparative prognostic value of three frailty-assessment tools in older patients with heart failure: post hoc analysis of the FRAGILE-HF cohort. Age Ageing. 2026. PMID: 41734100. doi:10.1093/ageing/afag031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。